Using ketamine to treat severe acute brain injuries
Official title: S-ketamine for Cortical Spreading Depolarisation in Patients With Severe Acute Brain Injury
Run by Copenhagen University Hospital, Rigshospitalet · NCT05095857 · Data updated 2026-11-12
This study is testing if S-ketamine can help people with severe brain injuries feel better and improve their recovery compared to a placebo.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | September 15, 2023 |
| Main results expected | September 15, 2028 |
| Study ends | September 15, 2028 |
| Registry record updated | June 26, 2024 |
| Trial ID | NCT05095857 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have been admitted to the neuro-intensive care unit with specific types of severe acute brain injuries and are planned for surgery.
✕Probably not a fit
Patients who are not undergoing surgery or have conditions such as known allergies to S-ketamine or active anti-psychotic treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the efficacy and safety of S-ketamine in patients suffering from severe acute brain injuries, such as traumatic brain injury and hemorrhages. It focuses on the role of cortical spreading depolarisations, which are linked to poor outcomes in these patients. Participants will be randomly assigned to receive either S-ketamine or a placebo while being monitored in a neuro-intensive care unit. The study aims to assess the feasibility of this treatment approach and its potential to improve neurological outcomes.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery outcomes for patients with severe acute brain injuries.
How similar studies have gone: While the use of ketamine in this context is novel, preliminary evidence suggests it may inhibit harmful brain activity, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years. * Admitted to the NICU with a diagnosis of traumatic brain injury (TBI), aneurysmal subarachnoid haemorrhage (aSAH) or spontaneous intracerebral haemorrhage (ICH). * Planned for surgery with a supratentorial craniotomy or craniectomy. * Expected to continue sedation and mechanical ventilation after surgery. Exclusion Criteria: * Neither patient or next of kin understand Danish or English. * Known allergy to S-ketamine (the active pharmaceutical ingredient or the excipients). * Wake-up call to occur immediately after surgery. * Pregnancy (all female participants aged ≤ 50 years will have a urine or blood hCG taken to control for pregnancy). * Active anti-psychotic treatment before admission. * Current abuse of ketamine. * Decision to withdraw active treatment. * ICH secondary to a known brain tumour at the time of inclusion. Since this is an emergency trial informed consent will be obtained from a trial guardian before inclusion of the participant, and informed consent will be sought from next of kin as soon as possible.
Where it's running
-
Rigshospitalet
Copenhagen, Denmark Recruiting
Study contacts
- Principal investigator: Trine H Andreasen, MD — Copenhagen University Hospital, Rigshospitalet
- Study coordinator: Trine H Andreasen, MD
- Email: trine.hjorslev.andreasen@regionh.dk
- Phone: +4535455982
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Augmented kidney clearance in neurocritical care
This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Non-invasive measurement of brain pressure in patients with traumatic brain injury
This study is testing a new non-invasive device to measure brain pressure in patients with traumatic brain injury to see if it can replace the need for more risky surgical methods.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms
This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.